Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-03-28 16:50:50
Reporting Period:
Filing Date:
Accepted Time:
2017-03-28 16:50:50
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
819050 Vical Inc VICL Biological Products, (No Disgnostic Substances) (2836) 930948554
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478907 Alan Anthony Ramos 10390 Pacific Center Court
San Diego CA 92121
Vp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Disposition 2017-03-27 4,250 $2.17 9,674 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Sale of 4,250 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on June 6, 2016.
  2. Represents a weighted average sales price per share. The prices actually received ranged from $2.10 to $2.22. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Such number reflects the 1-for-10 reverse stock split of the issuer's common stock on May 26, 2016, resulting in the Reporting Person's ownership of 125,311 fewer shares of common stock. The balance includes 3,000 unvested shares subject to restricted stock units.